These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 14965028)

  • 21. Immunizations against bioterrorism: smallpox and anthrax.
    Margolis AR; Grabenstein JD
    J Am Pharm Assoc (2003); 2009; 49(4):566-8. PubMed ID: 19589771
    [No Abstract]   [Full Text] [Related]  

  • 22. [Infections by Bacillus anthracis].
    Biederbick W; Fock R; Güttler K; Veit C
    Dtsch Med Wochenschr; 2002 Apr; 127(15):809-14. PubMed ID: 11951140
    [No Abstract]   [Full Text] [Related]  

  • 23. Experts focus on infective agents of bioterrorism.
    Stephenson J
    JAMA; 2002 Feb; 287(5):575-6. PubMed ID: 11829676
    [No Abstract]   [Full Text] [Related]  

  • 24. The US capitol bioterrorism anthrax exposures: clinical epidemiological and immunological characteristics.
    Doolan DL; Freilich DA; Brice GT; Burgess TH; Berzins MP; Bull RL; Graber NL; Dabbs JL; Shatney LL; Blazes DL; Bebris LM; Malone MF; Eisold JF; Mateczun AJ; Martin GJ
    J Infect Dis; 2007 Jan; 195(2):174-84. PubMed ID: 17191162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Science and the fight against bioterrorism.
    Rieff HI
    FASEB J; 2002 Jan; 16(1):1. PubMed ID: 11772930
    [No Abstract]   [Full Text] [Related]  

  • 26. [Vaccination strategies for anthrax prevention].
    Beyer W
    Berl Munch Tierarztl Wochenschr; 2004; 117(11-12):508-24. PubMed ID: 15584433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bacillus anthracis: current knowledge in relation to contamination of food.
    Erickson MC; Kornacki JL
    J Food Prot; 2003 Apr; 66(4):691-9. PubMed ID: 12696699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccines: countering anthrax: vaccines and immunoglobulins.
    Grabenstein JD
    Clin Infect Dis; 2008 Jan; 46(1):129-36. PubMed ID: 18171228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The anthrax bacterium--a biological masterpiece with deadly potential].
    Myhre EB
    Lakartidningen; 2002 Feb; 99(6):484-7. PubMed ID: 11881219
    [No Abstract]   [Full Text] [Related]  

  • 30. CDC has anthrax, smallpox vaccination guidelines available.
    Traynor K
    Am J Health Syst Pharm; 2001 Nov; 58(21):2008, 2011. PubMed ID: 11715817
    [No Abstract]   [Full Text] [Related]  

  • 31. Advances in the development of next-generation anthrax vaccines.
    Friedlander AM; Little SF
    Vaccine; 2009 Nov; 27 Suppl 4():D28-32. PubMed ID: 19837282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective activity and immunogenicity of two recombinant anthrax vaccines for veterinary use.
    Fasanella A; Tonello F; Garofolo G; Muraro L; Carattoli A; Adone R; Montecucco C
    Vaccine; 2008 Oct; 26(45):5684-8. PubMed ID: 18775462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Current status of anthrax or black fever].
    Chantal J
    Med Trop (Mars); 1997; 57(3 Suppl):52-60. PubMed ID: 9513179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunogenicity of the recombinant Bacillus strains with cloned gene of biosynthesis of protective antigen against Bacillus anthracis].
    Mikshis NI; Kudriavtseva OM; Bolothikova MF; Shulepov DV; Novikova LV; Popov IuA; Shchukovskaia TN; Drozdov IG; Kutyrev VV
    Mol Gen Mikrobiol Virusol; 2007; (3):15-21. PubMed ID: 17886469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA vaccines against anthrax.
    Galloway DR; Baillie L
    Expert Opin Biol Ther; 2004 Oct; 4(10):1661-7. PubMed ID: 15461577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Catalytically inactive anthrax toxin(s) are potential prophylactic agents.
    Gupta M; Alam S; Bhatnagar R
    Vaccine; 2007 Dec; 25(50):8410-9. PubMed ID: 17980467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Passive immunotherapy of Bacillus anthracis pulmonary infection in mice with antisera produced by DNA immunization.
    Herrmann JE; Wang S; Zhang C; Panchal RG; Bavari S; Lyons CR; Lovchik JA; Golding B; Shiloach J; Lu S
    Vaccine; 2006 Jul; 24(31-32):5872-80. PubMed ID: 16790303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Zoonosis update. Anthrax.
    Shadomy SV; Smith TL
    J Am Vet Med Assoc; 2008 Jul; 233(1):63-72. PubMed ID: 18593313
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunogenicity of a subunit vaccine against Bacillus anthracis.
    Chichester JA; Musiychuk K; de la Rosa P; Horsey A; Stevenson N; Ugulava N; Rabindran S; Palmer GA; Mett V; Yusibov V
    Vaccine; 2007 Apr; 25(16):3111-4. PubMed ID: 17280756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Engineered chloroplasts as vaccine factories to combat bioterrorism.
    Streatfield SJ
    Trends Biotechnol; 2006 Aug; 24(8):339-42. PubMed ID: 16815579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.